FDA MedWatch Safety AlertsOriginal article
Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
RegulatoryThyroid Tablets, USP 30 mgNegative
AI Analysis
Summary
Vitruvias Therapeutics initiated a voluntary nationwide recall of one lot of Thyroid Tablets, USP 30 mg due to confirmed superpotency. The recall affects Lot No. 504950 and reaches the consumer level.
Outcome Details
Voluntary recall of Lot No. 504950 due to superpotency
Importance:5/10
Sentiment:
-0.80
recallproduct_safetysuperpotencyFDAquality_control
Read the original article
Published by FDA MedWatch Safety Alerts on August 24, 2026 4:00 AM